Form 4: Camp4 Therapeutics Director Michael J Higgins Granted 9,000 Stock Options

Camp4 Therapeutics Corp. director Michael J Higgins was granted 9,000 stock options with an exercise price of $1.56, vesting on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders.

Summary

• Michael J Higgins, a Director of Camp4 Therapeutics Corp. (CAMP), was granted 9,000 stock options.
• The options have an exercise price of $1.56 per share.
• The grant date for these options was June 25, 2025.
• The options vest in their entirety on the earlier of the first anniversary of the grant date (June 25, 2026) or the date of the issuer's next annual meeting of stockholders.
• Vesting is contingent upon Mr. Higgins' continued service to the issuer's board of directors through the applicable vesting date.
• The options expire on June 24, 2035.
• Following this transaction, Mr. Higgins beneficially owns 9,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a positive step for aligning interests, but it's a routine compensation event and doesn't indicate significant new developments or financial performance.

Positives

• The grant of stock options aligns the director's interests with those of shareholders, incentivizing long-term performance.
• The options provide a potential future equity stake for the director at a fixed exercise price of $1.56.

Risks

• The value of the stock options is dependent on the future market price of Camp4 Therapeutics Corp. common stock exceeding the exercise price of $1.56.
• Vesting of the options is subject to the director's continued service to the board.

Future Outlook

The stock options are designed to vest on the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders, subject to continued service, indicating a future incentive for the director.

Industry Context

This Form 4 filing represents a routine insider transaction, specifically the grant of stock options as part of director compensation, a common practice across various industries to align executive and board member interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant of stock options aims to align the director's interests with shareholders by incentivizing an increase in the company's stock price.

Next Steps

• The stock options will vest on the earlier of June 25, 2026, or the date of the issuer's next annual meeting of stockholders, provided the director continues service.

Key Dates

Keywords

Camp4 Therapeutics Corp, CAMP, Stock Options, Director Compensation, SEC Form 4, Insider Trading, Equity Grant, Michael J Higgins